155 related articles for article (PubMed ID: 16622040)
41. Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics.
Solt K; Eger EI; Raines DE
Anesth Analg; 2006 May; 102(5):1407-11. PubMed ID: 16632818
[TBL] [Abstract][Full Text] [Related]
42. Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-D-aspartate (NMDA) receptors.
Sugimoto M; Uchida I; Mashimo T
Br J Pharmacol; 2003 Mar; 138(5):876-82. PubMed ID: 12642389
[TBL] [Abstract][Full Text] [Related]
43. Determinants of the sensitivity of AMPA receptors to xenon.
Plested AJ; Wildman SS; Lieb WR; Franks NP
Anesthesiology; 2004 Feb; 100(2):347-58. PubMed ID: 14739810
[TBL] [Abstract][Full Text] [Related]
44. Anesthetic and ethanol effects on spontaneously opening glycine receptor channels.
Beckstead MJ; Phelan R; Trudell JR; Bianchini MJ; Mihic SJ
J Neurochem; 2002 Sep; 82(6):1343-51. PubMed ID: 12354281
[TBL] [Abstract][Full Text] [Related]
45. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
Williams K
Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
[TBL] [Abstract][Full Text] [Related]
46. Evidence that Xenon does not produce open channel blockade of the NMDA receptor.
Weigt HU; Adolph O; Georgieff M; Georgieff EM; Föhr KJ
J Neurophysiol; 2008 Apr; 99(4):1983-7. PubMed ID: 18234987
[TBL] [Abstract][Full Text] [Related]
47. Ethanol inhibits glutamate-induced currents in heteromeric NMDA receptor subtypes.
Kuner T; Schoepfer R; Korpi ER
Neuroreport; 1993 Dec; 5(3):297-300. PubMed ID: 7905294
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of gabapentin on N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Hara K; Sata T
Acta Anaesthesiol Scand; 2007 Jan; 51(1):122-8. PubMed ID: 17073851
[TBL] [Abstract][Full Text] [Related]
49. Alcohols and anesthetics enhance the function of 5-hydroxytryptamine3 receptors expressed in Xenopus laevis oocytes.
Machu TK; Harris RA
J Pharmacol Exp Ther; 1994 Nov; 271(2):898-905. PubMed ID: 7965811
[TBL] [Abstract][Full Text] [Related]
50. Differential sensitivity of expressed L-type calcium channels and muscarinic M(1) receptors to volatile anesthetics in Xenopus oocytes.
Kamatchi GL; Durieux ME; Lynch C
J Pharmacol Exp Ther; 2001 Jun; 297(3):981-90. PubMed ID: 11356920
[TBL] [Abstract][Full Text] [Related]
51. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
52. High-affinity Zn block in recombinant N-methyl-D-aspartate receptors with cysteine substitutions at the Q/R/N site.
Amar M; Perin-Dureau F; Neyton J
Biophys J; 2001 Jul; 81(1):107-16. PubMed ID: 11423399
[TBL] [Abstract][Full Text] [Related]
53. Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine.
Yamakura T; Chavez-Noriega LE; Harris RA
Anesthesiology; 2000 Apr; 92(4):1144-53. PubMed ID: 10754635
[TBL] [Abstract][Full Text] [Related]
54. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E
Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254
[TBL] [Abstract][Full Text] [Related]
55. Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner.
Masuko T; Suzuki I; Kizawa Y; Kusama-Eguchi K; Watanabe K; Kashiwagi K; Igarashi K; Kusama T
Neurosci Lett; 2004 Nov; 371(1):30-3. PubMed ID: 15500961
[TBL] [Abstract][Full Text] [Related]
56. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
Buller AL; Monaghan DT
Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
[TBL] [Abstract][Full Text] [Related]
58. Volatile aromatic anesthetics variably impact human gamma-aminobutyric acid type A receptor function.
Kelly EW; Solt K; Raines DE
Anesth Analg; 2007 Nov; 105(5):1287-92, table of contents. PubMed ID: 17959956
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of 5-hydroxytryptamine type 2A receptor-induced currents by n-alcohols and anesthetics.
Minami K; Minami M; Harris RA
J Pharmacol Exp Ther; 1997 Jun; 281(3):1136-43. PubMed ID: 9190846
[TBL] [Abstract][Full Text] [Related]
60. Modulation of NMDA receptor function by ketamine and magnesium: Part I.
Liu HT; Hollmann MW; Liu WH; Hoenemann CW; Durieux ME
Anesth Analg; 2001 May; 92(5):1173-81. PubMed ID: 11323343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]